Animal Microbiome Market Size and Scope 2026 to 2035
Share With :
Global Animal Microbiome Market Size is valued at USD 7.66 Billion in 2025 and is predicted to reach USD 22.33 Billion by the year 2035 at a 11.70% CAGR during the forecast period for 2026 to 2035.
Animal Microbiome Market Size, Share & Trends Analysis Report By Product (Phage Therapy Product, Functional Food, Sequencing Platforms, Feed Additives/Functional Ingredients, Alternative Proteins and Alternative Feed, Other), By Application, By Animal Type, By Region, And Segment Forecasts, 2026 to 2035.
Animal Microbiome Market Key Takeaways:
|
Animal Microbiomes are referred to as the communities of micro-organisms such as viruses, bacteria, and fungi that symbiotically live around, on, and in animals which contribute to animal well-being and health. Microbiomes in animals are key to maintaining the healthy function of their diverse ecosystems. Animal Microbiomes find the critical range of application in Poultry, Ruminants, Swine, Aquaculture, and Pets. By region, In 2021, Asia Pacific dominates the market with a share of 35.4% of the global Animal Microbiome market. China and India are the key markets holding the majority of the market for Animal Microbiome in the region.
The global poultry and livestock population is anticipated to rise in the next couple of years to a significant extent. According to the USDA Foreign Agricultural Service report 2019, world cattle inventory is anticipated to be around 1,001,841,000. The market is primarily driven by the rising livestock population and the domestic animal trend is especially prominent in developing countries such as China, India, and Brazil. India has the largest cattle population with approximately 30.4% of global cattle inventory. China has positioned itself as a world leader in pork production, and its animal-derived dietary production has increased from less than 70 million tons in 2010 to more than 76 million tons in 2016. The rapid increase in research and development in the animal microbiome industry along with rising awareness about antibiotic-free animal-derived products for animal health and wellbeing has been seen in recent years has further created significant market opportunities in upcoming years.
The global Animal Microbiome market is segmented on the basis of product, application, and region. Based on the products, the market is divided into Therapeutic/Pharma Products, Phage Therapy Product, Functional Food, Medical Food, and Dietary Supplement. On the basis of application type, the market is segmented into Poultry, Ruminants, Swine, Aquaculture, and Pets. Based on region, the market is studied across North America, Asia-Pacific, Europe, and LAMEA. Among that, Europe held the largest share of the market, followed by America and the Asia Pacific. On the other hand, North America is expected to dominate the market during the analysis of the forecast period.
| Report Attribute | Specifications |
| Market Size Value In 2025 | USD 7.66 Billion |
| Revenue Forecast In 2035 | USD 22.33 Billion |
| Growth Rate CAGR | CAGR of 11.70% from 2026 to 2035 |
| Quantitative Units | Representation of revenue in US$ Mn and CAGR from 2026 to 2035 |
| Historic Year | 2022 to 2025 |
| Forecast Year | 2026-2035 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Product, By Application, By Animal Type |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
| Competitive Landscape | Animal Biome, Inc., ANIZOME LLC, Cargill, Chr. Hansen Holding A/S, Cytophage Technologies Inc., DuPont Industrial Biosciences, Elanco Animal Health, EnBiotix, Inc., Gnubiotics Sciences SA, Hill's Pet Nutrition, Inc., Intralytix, Koninklijke DSM N.V. (Royal DSM), Lallemand Inc., Land O'Lakes, Inc., Leiber GmbH, MicroSintesis, NomNomNow Inc., Novozymes A/S, Orion Pharma Animal Health, Phage Technologies SA, Phagelux, Inc., Phibro Animal Health Corporation, ProDigest, Tonicity International Limited, and VetoPhage. |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.